Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huizhe Wu

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Pharmaceutics|January 26, 2019
Pharmacodynamics and Pharmacokinetics of a New Type of Compound Lansoprazole Capsule in Gastric Ulcer Rats and Beagle Dogs: Importance of Adjusting Oxidative Stress and InflammationBinbin Wei, Yan Wang, Huizhe Wu, et al.
Aging|November 17, 2020
Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylationYilin Wang, Ming Zhang, Xiaoyun Hu, et al.
Cancer Cell|December 25, 2025
Epitranscriptomic control of cancer hallmarks: Functions, mechanisms, and therapeutics of RNA modificationsXiaolan Deng, Dong Wu, Yingqi Zhao, et al.
Biomed Research International|September 9, 2015
A Locked Nucleic Acid Probe Based on Selective Salt-Induced Effect Detects Single Nucleotide PolymorphismsJing Zhang, Huizhe Wu, Qiuchen Chen, et al.
Clinical Therapeutics|April 20, 2010
Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteersHuizhe Wu, Mingyan Liu, Shuang Wang, et al.
Molecular Cancer|September 13, 2017
Cell-specific mechanisms of TMEM16A Ca<sup>2+</sup>-activated chloride channel in cancerHui Wang, Liang Zou, Ke Ma, et al.
Trends in Pharmacological Sciences|March 19, 2026
Cuproptosis in cancer: emerging mechanism and therapeutic opportunitiesWenyan Qin, Huan Sheng, Xiaoyun Hu, et al.
Medical Oncology (Northwood, London, England)|December 10, 2014
STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomesHaishan Zhao, Zhe Wang, Huizhe Wu, et al.
Aging|November 18, 2020
Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancerBoshi Fu, Cheng Du, Zhikun Wu, et al.
Biomed Research International|December 4, 2015
Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based ChemotherapyHuizhe Wu, Yong Liu, Hui Kang, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Pharmaceutics|January 26, 2019
Pharmacodynamics and Pharmacokinetics of a New Type of Compound Lansoprazole Capsule in Gastric Ulcer Rats and Beagle Dogs: Importance of Adjusting Oxidative Stress and InflammationBinbin Wei, Yan Wang, Huizhe Wu, et al.
Aging|November 17, 2020
Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylationYilin Wang, Ming Zhang, Xiaoyun Hu, et al.
Cancer Cell|December 25, 2025
Epitranscriptomic control of cancer hallmarks: Functions, mechanisms, and therapeutics of RNA modificationsXiaolan Deng, Dong Wu, Yingqi Zhao, et al.
Biomed Research International|September 9, 2015
A Locked Nucleic Acid Probe Based on Selective Salt-Induced Effect Detects Single Nucleotide PolymorphismsJing Zhang, Huizhe Wu, Qiuchen Chen, et al.
Clinical Therapeutics|April 20, 2010
Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteersHuizhe Wu, Mingyan Liu, Shuang Wang, et al.
Molecular Cancer|September 13, 2017
Cell-specific mechanisms of TMEM16A Ca<sup>2+</sup>-activated chloride channel in cancerHui Wang, Liang Zou, Ke Ma, et al.
Trends in Pharmacological Sciences|March 19, 2026
Cuproptosis in cancer: emerging mechanism and therapeutic opportunitiesWenyan Qin, Huan Sheng, Xiaoyun Hu, et al.
Medical Oncology (Northwood, London, England)|December 10, 2014
STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomesHaishan Zhao, Zhe Wang, Huizhe Wu, et al.
Aging|November 18, 2020
Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancerBoshi Fu, Cheng Du, Zhikun Wu, et al.
Biomed Research International|December 4, 2015
Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based ChemotherapyHuizhe Wu, Yong Liu, Hui Kang, et al.
Pageof 7